Biora Therapeutics, Inc. Common Stock
BIOR
BIOR was delisted on the 10th of December, 2024.
27 hedge funds and large institutions have $13.3M invested in Biora Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 7 closing their positions.
1,785% more call options, than puts
Call options by funds: $509K | Put options by funds: $27K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
7% less funds holding
Funds holding: 29 → 27 (-2)
18% less capital invested
Capital invested by funds: $16.1M → $13.3M (-$2.82M)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$115K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$73.7K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$57.4K |
| 4 |
Jane Street
New York
|
+$19.2K |
| 5 |
LRIA
Leonard Rickey Investment Advisors
Yakima,
Washington
|
+$17.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$55K |
| 2 |
EGM
Engineers Gate Manager
New York
|
-$20.4K |
| 3 |
Millennium Management
New York
|
-$16.1K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$11.7K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$10.3K |
BIOR Hedge Fund Activity: Q1 2024 in Review
27 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Biora Therapeutics, Inc. Common Stock (BIOR) for Q1 2024, worth a combined $13.3M — down 18% from $16.1M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of BIOR and 5 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 6 added.
The largest buyer was Geode Capital Management, adding an estimated $115K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $55K sold.
- 27 institutional investors held Biora Therapeutics, Inc. Common Stock (BIOR) as of Q1 2024, down from 29 in Q4 2023.
- Funds reported $13.3M of Biora Therapeutics, Inc. Common Stock stock for Q1 2024, down 18% quarter-over-quarter.
- 5 funds opened new Biora Therapeutics, Inc. Common Stock positions in Q1 2024 and 7 closed out, a net change of -2 holders.
- The largest Biora Therapeutics, Inc. Common Stock buyer in Q1 2024 was Geode Capital Management, an estimated $115K added.
- The largest Biora Therapeutics, Inc. Common Stock seller in Q1 2024 was Susquehanna International Group, an estimated $55K sold.
Based on aggregated 13F filings for Q1 2024.